BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38287354)

  • 1. The impact of lymphadenectomy on ovarian clear cell carcinoma: a systematic review and meta-analysis.
    Liu Y; Geng F; Zhang H; Xue J; Chu R
    World J Surg Oncol; 2024 Jan; 22(1):37. PubMed ID: 38287354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma.
    Yamazaki H; Todo Y; Shimada C; Takeshita S; Minobe S; Okamoto K; Yamashiro K; Kato H
    J Gynecol Oncol; 2018 Mar; 29(2):e19. PubMed ID: 29400012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study.
    Zhu C; Zhu J; Qian L; Liu H; Shen Z; Wu D; Zhao W; Xiao W; Zhou Y
    BMC Cancer; 2021 Mar; 21(1):322. PubMed ID: 33766002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of lymphadenectomy on the survival outcomes of ovarian clear cell carcinoma: A retrospective study of the SEER database and Chinese registry.
    Liu Y; Zhao W; Huang C; Chu R; Li Z; Wang Y; Song L; Li L
    Eur J Surg Oncol; 2024 Mar; 50(3):107975. PubMed ID: 38295548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion.
    Matsuo K; Yoshino K; Hasegawa K; Murakami R; Ikeda Y; Adachi S; Hiramatsu K; Yokoyama T; Nishimura M; Sheridan TB; Enomoto T; Fujiwara K; Matsumura N; Konishi I; Fotopoulou C; Roman LD; Sood AK
    Gynecol Oncol; 2015 Feb; 136(2):198-204. PubMed ID: 25497604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
    Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR
    Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?
    Sahin H; Sari ME; Cuylan ZF; Haberal AN; Sirvan L; Coban G; Yalcin I; Güngör T; Celik H; Meydanli MM; Ayhan A
    Arch Gynecol Obstet; 2018 Apr; 297(4):1005-1013. PubMed ID: 29383437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis.
    Chiyoda T; Sakurai M; Satoh T; Nagase S; Mikami M; Katabuchi H; Aoki D
    J Gynecol Oncol; 2020 Sep; 31(5):e67. PubMed ID: 32808497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian clear cell carcinoma with or without endometriosis origin in a single institution cohort.
    Sun M; Jiang W
    Discov Oncol; 2023 Apr; 14(1):39. PubMed ID: 37004660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
    Bizzarri N; Imterat M; Fruscio R; Giannarelli D; Perrone AM; Mancari R; Traut A; Rosati A; du Bois A; Ferrari D; De Iaco P; Ergasti R; Ataseven B; Bianchi T; Di Stanislao M; Perri MT; Heitz F; Concin N; Fanfani F; Vizza E; Scambia G; Harter P; Fagotti A
    Eur J Cancer; 2023 Dec; 195():113398. PubMed ID: 37890354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2018 Jan; 28(1):11-18. PubMed ID: 28930811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and survival characteristic of mismatch repair status in ovarian clear cell carcinoma.
    Zhu J; Ke G; Bi R; Wu X
    J Surg Oncol; 2020 Sep; 122(3):538-546. PubMed ID: 32396667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY).
    Uccella S; Nero C; Vizza E; Vargiu V; Corrado G; Bizzarri N; Ghezzi F; Cosentino F; Turco LC; Fagotti A; Scambia G
    Am J Obstet Gynecol; 2019 Oct; 221(4):324.e1-324.e10. PubMed ID: 31082385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of lymph node dissection for adenocarcinoma of the stomach.
    Mocellin S; McCulloch P; Kazi H; Gama-Rodrigues JJ; Yuan Y; Nitti D
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD001964. PubMed ID: 26267122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
    Oliver KE; Brady WE; Birrer M; Gershenson DM; Fleming G; Copeland LJ; Tewari K; Argenta PA; Mannel RS; Secord AA; Stephan JM; Mutch DG; Stehman FB; Muggia FM; Rose PG; Armstrong DK; Bookman MA; Burger RA; Farley JH
    Gynecol Oncol; 2017 Nov; 147(2):243-249. PubMed ID: 28807367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer.
    Matsuo K; Machida H; Mariani A; Mandelbaum RS; Glaser GE; Gostout BS; Roman LD; Wright JD
    J Gynecol Oncol; 2018 Sep; 29(5):e69. PubMed ID: 30022633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of systematic lymphadenectomy during debulking surgery in the treatment of ovarian cancer: a meta-analysis of randomized controlled trials.
    Lin Q; Liu W; Xu S; Li J; Tong J
    J Ovarian Res; 2020 May; 13(1):56. PubMed ID: 32384898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?
    Bizzarri N; du Bois A; Fruscio R; De Felice F; De Iaco P; Casarin J; Vizza E; Chiantera V; Corrado G; Cianci S; Magni S; Ferrari D; Giuliani D; Harter P; Ataseven B; Bommert M; Perrone AM; Scambia G; Fagotti A
    Gynecol Oncol; 2021 Jan; 160(1):56-63. PubMed ID: 33168305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of lymph node involvement or lymphadenectomy on prognosis of patients with borderline ovarian tumors: A systematic review and meta-analysis.
    Fan Y; Zhang YF; Wang MY; Mu Y; Mo SP; Li JK
    Gynecol Oncol; 2021 Sep; 162(3):797-803. PubMed ID: 34119365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the number of cycles of platinum-based chemotherapy for early stage ovarian clear cell carcinoma on survival: a retrospective study.
    Gao Y
    BMC Womens Health; 2023 May; 23(1):262. PubMed ID: 37189098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.